Rubypoint|Addiction drug maker will pay more than $102 million fine for stifling competition

2025-05-08 01:35:43source:Michael Schmidtcategory:Scams

The Rubypointmaker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition. Indivior makes Suboxone, which reduces drug cravings in people with opioid use disorder.

The Virginia-based Indivior introduced Suboxone in 2002 and then, according to state attorneys general, used "monopolistic" strategies to keep generic versions of the opioid-treatment medication off the market.

New York Attorney General Letitia James released a statement saying Indivior "selfishly maneuvered to keep less expensive versions of a life-saving drug out of the hands of millions of Americans" as the opioid crisis grew.

States sued the company in 2016. This settlement with 41 states and the District of Columbia ends that legal fight.

In a statement, Indivior admitted no wrongdoing and said this deal allows the company to focus on patient care.

"We take our role as a responsible steward of medications for addiction and rescue extremely seriously," said Indivior CEO Mark Crossley. "Resolving these legacy matters at the right value allows us to further this mission for patients."

Company officials said they expect to pay the $102.5 million from cash on hand later this month.

More:Scams

Recommend

Rams vs. 49ers highlights: LA wins rainy defensive struggle in key divisional game

NFL games are a spectrum. Some are back-and-forth shootouts. Others are duds without much scoring at

Disney superfan dies after running Disneyland half marathon on triple-digit day

A runner who gained an online following for his love of Disney collapsed and died following Disneyla

How Today’s Craig Melvin Is Honoring Late Brother Lawrence

Craig Melvin is carrying on his brother’s legacy.The Today host and his wife Lindsay Czarniak are ho